Merck Stops Selling Recarbrio in the U.S., Leaving Hospitals with Fewer Options for Drug-Resistant Pneumonia and Infections
Merck has discontinued Recarbrio, a reserve IV antibiotic for resistant hospital infections, in the U.S. Here is what patients and families should know.
Medical Daily ·